Carna Biosciences Inc.

Carna Biosciences Inc. of Kobe, Japan, a provider of intercellular drug discovery programs and services, has signed an agreement with Caliper Life Sciences Inc. of Hopkinton, Mass. The collaboration will provide the latter with protein kinases and ProfilerPro Kinase Selectivity Assay Kits. Combining advanced devices with reagents will influence therapy for cancer and neurological and autoimmune diseases.





LATEST NEWS

• CLEO Heads to the East Coast
  Apr 29, 2024
• Laser-Based Gas Analyzer Developed to Detect Air Pollution
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024
• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024